Patents Assigned to Galvani, Ltd.
  • Patent number: 8401637
    Abstract: A method and system for treating an individual experiencing cardiac arrest using an automatic external defibrillator (AED) includes placing a first and a second electrode of the AED in electrical communication with an exterior surface of the individual. A need to apply a high voltage defibrillation signal to the individual is automatically determined. The method also includes automatically causing the AED to apply a medium voltage therapy (MVT) signal through the first and the second electrodes to the individual. The MVT signal is applied to induce a hemodynamic effect in the individual. Alternatively, or additionally, the MVT signal is applied to induce a respiratory effect in the individual. Optionally, the MVT signal is applied before determining the need to apply the defibrillation signal.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: March 19, 2013
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark Kroll, Tom Bugliosi
  • Patent number: 7706864
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. Forcing fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: April 27, 2010
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 6853859
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. Forcing fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: February 8, 2005
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 6567697
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. Forcing fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: May 20, 2003
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 6560484
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. Forcing fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: May 6, 2003
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 6351670
    Abstract: A method and apparatus for monitoring syncope, and having available for use an electrical cardiac output forcing (ECOF) back up. An implantable device, including an ECOF back up, for recording the electrical activity within a human heart is provided. The device includes a power supply for operating the device and for providing the necessary output forcing signals. A monitoring or detection device is provided connected to the power supply. Electrodes are provided to electrically connect the power supply and the detection device to a patient's heart. A memory device is also provided connected to the detection device for recording electrical activity and/or blood pressure data of the patient's heart. The memory device may be comprised of a short term loop buffer for continuously recording the electrical data from the patient's heart and a long term storage buffer. The short term loop may be of a desired size, for example, capable of storing from 1-30 minutes of data before overriding occurs.
    Type: Grant
    Filed: September 8, 1999
    Date of Patent: February 26, 2002
    Assignee: Galvani, Ltd.
    Inventor: Kai Kroll
  • Patent number: 6314319
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. Forcing fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: February 17, 1999
    Date of Patent: November 6, 2001
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 6230056
    Abstract: A device for preventing clotting during atrial fibrillation includes optional electrical cardiac output forcing (ECOF) or ICD/AED back up. The device includes a power supply for operating the device and for providing the necessary output forcing signals. The power supply is located in a housing which may be implantable into a human patient. In one embodiment, the housing acts as an electrode. At least one additional electrode is connected to the housing and may be inserted into the human heart. A ventricular lead is mounted to the electrode along with an atrial lead. The housing also contains an electrical cardiac stimulator. When a certain cardiac event, such as atrial fibrillation, is detected, anti-clotting pulses are applied to the heart via the atrial lead. If and when ventricular fibrillation is detected, further pulses of a different voltage level are applied to the heart via the ventricular lead. In one embodiment, the anti-clotting pulses are synchronized to the R-wave sensed by the ventricular lead.
    Type: Grant
    Filed: September 8, 1999
    Date of Patent: May 8, 2001
    Assignee: Galvani, Ltd.
    Inventor: Kai Kroll
  • Patent number: 6185457
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. Forcing fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: February 6, 2001
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 6167306
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. Forcing fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: December 26, 2000
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 5978703
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. High level electrical fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: December 6, 1996
    Date of Patent: November 2, 1999
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 5925066
    Abstract: An atrial arrythmia sensor and drug dispensing apparatus is disclosed. The apparatus comprises a multiphase, multistage intelligent system to monitor and treat atrial fibrillation. The apparatus includes atrial rate sensing means, cardiac pacing and antitachycardia pacing means, drug delivery means including a self-cleaning catheter line with multi-drug dispensing capability preferably operated using a dual pump arrangement and an iontophoretic device. The drug delivery system may also include a porous catheter to discharge drug into the atrium. The intelligent system includes a memory implemented logic (software) to continuously monitor the atrial rate and initiate a response of either cardiac pacing, antitachycardia pacing or drug dispensing based on preset cardiac activity parameters. The system also includes a medical history recording feature.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: July 20, 1999
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 5782883
    Abstract: An implantable device for, in the event of ventricular fibrillation, temporarily electrically forcing cardiac output to maintain life and consciousness in a patient until the patient is rescued by an external defibrillator. The device uses moderate voltage output pulses of 30-200 V which are sufficient to cause a partial contraction of the heart even if it is fibrillating. These pulses are not typically sufficient to defibrillate the heart and this device cannot substitute as a defibrillator. However, the moderate voltage pulsing will generate enough cardiac output to keep the patient alive. The system is designed with sufficient battery power for years of monitoring and hours of cardiac output forcing operation.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: July 21, 1998
    Assignee: Galvani Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 5735876
    Abstract: An implantable device for temporarily maintaining cardiac output through the use of electrical forcing fields in the event of an atrial defibrillation shock causing ventricular fibrillation. The device includes an atrial defibrillator. In the event that an atrial defibrillation shock causes a ventricular fibrillation the apparatus and method then delivers a continuous train of modest voltage pulses to force partial cardiac contractions to maintain life and consciousness until the patient can receive external defibrillation.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: April 7, 1998
    Assignee: Galvani Ltd.
    Inventors: Kai Kroll, Mark W. Kroll
  • Patent number: 5584866
    Abstract: An electrical method and apparatus for stimulating cardiac cells causing contraction to force hemodynamic output during fibrillation, hemodynamically compromising tachycardia, or asystole. High level electrical fields are applied to the heart to give cardiac output on an emergency basis until the arrhythmia ceases or other intervention takes place. The device is used as a stand alone external or internal device, or as a backup to an ICD, atrial defibrillator, or an anti-tachycardia pacemaker. The method and apparatus maintain some cardiac output and not necessarily defibrillation.
    Type: Grant
    Filed: October 13, 1995
    Date of Patent: December 17, 1996
    Assignee: Galvani, Ltd.
    Inventors: Kai Kroll, Mark W. Kroll